Last updated on February 2020

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer


Brief description of study

NuTide:121 compares NUC-1031 with gemcitabine, both in combination with cisplatin, in patients with previously untreated advanced biliary tract cancer.

The primary hypotheses are:

  • The combination of NUC-1031 plus cisplatin prolongs overall survival compared to the gemcitabine plus cisplatin standard of care
  • The combination of NUC-1031 plus cisplatin increases overall response rate compared to the gemcitabine plus cisplatin standard of care

Clinical Study Identifier: NCT04163900

Find a site near you

Start Over

Warringal Medical Centre

Heidelberg, Australia
3.47miles
  Connect »

The Alfred Hospital

Melbourne, Australia
6.21miles
  Connect »